SCHEMBL13811528

SCHEMBL13811528

COc1ccc(-c2nc(OCCN3CCC(F)(F)C3)nc3c2C(C#N)CN3)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 2/20 0.42
NSD2 O96028 2/20 0.38
MCHR1 Q99705 2/20 0.37
SMPD3 Q9NY59 1/20 0.36
HTR2C P28335 2/20 0.36
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR2A P28223 1/20 0.32
WHR1 P49842 1/20 0.32
FGFR1 P11362 2/20 0.32
FGFR2 P21802 2/20 0.32
FGFR4 P22455 2/20 0.32
FGFR3 P22607 2/20 0.32
KDR P35968 2/20 0.32
TTK P33981 1/20 0.32
ADORA2A P29274 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811571 0.80 HSP90AB1 (0.41) HSP90AB1MCHR1KDM4EALDH1A1HPGD
SCHEMBL13811530 0.74 HSP90AB1 (0.59) HSP90AB1NSD2MCHR1HTR2CHTR2A
SCHEMBL2568036 0.73 HSP90AB1 (0.55) HSP90AB1NSD2HTR2C
SCHEMBL13811529 0.70 HSP90AB1 (0.54) HSP90AB1NSD2HTR2CHTR2A
SCHEMBL12161188 0.66 HSP90AB1 (0.80) HSP90AB1NSD2
SCHEMBL2565242 0.65 HSP90AB1 (0.63) HSP90AB1NSD2
SCHEMBL5260766 0.65 MCHR1 (0.52) HSP90AB1NSD2MCHR1HTR2CKDM4E
SCHEMBL2563850 0.64 HSP90AB1 (0.60) HSP90AB1KDM4EALDH1A1
SCHEMBL5258701 0.61 MCHR1 (0.49) MCHR1HTR2CALDH1A1HPGD
SCHEMBL2564918 0.61 HSP90AB1 (0.73) HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163490-A1 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors VERNALIS (R&D) LTD. (GB) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163490-A1 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors HSP90AA1, HSP90AB1, RAF1 HSP90AB1 2/4885NSD2 2144/4885MCHR1 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.